These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9204605)

  • 1. Increased yield of F VIII from pooled plasma vs. single-donor plasma in the production of cryoprecipitates.
    Rácz Z; Thék M; Jánossy A; Pintér J; Baróti C
    Arch Med Res; 1997; 28(2):179-82. PubMed ID: 9204605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved thaw-siphon method for the cryoprecipitate preparation.
    Kang EP
    Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
    Budde U; Drewke E
    Beitr Infusionsther Transfusionsmed; 1994; 32():408-14. PubMed ID: 9422121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII-related activities in therapeutic concentrates.
    Barrowcliffe TW; Kemball-Cook G; Morris G; Holt JC; Furlong RA; Peake IR
    J Lab Clin Med; 1981 Mar; 97(3):429-38. PubMed ID: 6780643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
    Wensley RT; Snape TJ
    Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of plasma with high levels of ionised calcium in the production of model scale coagulation factor concentrates.
    Farrugia A; Douglas S; James J; Whyte G; Herrington R
    Thromb Haemost; 1990 Nov; 64(3):374-8. PubMed ID: 2128967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the procurement of coagulation factor VIII: selective precipitation of factor VIII with hydrophilic polymers.
    Farrugia A; Griffin B; Pepper D; Prowse C
    Thromb Haemost; 1984 Jul; 51(3):338-42. PubMed ID: 6437004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homo- and heterogeneous forms of human factor VIII.
    Vukovich TC
    Thromb Haemost; 1982 Aug; 48(1):98-100. PubMed ID: 6814000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophoretic studies of human plasma cryoprecipitates with a high content of antihemophilic globulin A].
    Kleint V; Wegner H
    Z Gesamte Inn Med; 1970 Apr; 25(7):312-4. PubMed ID: 5521442
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma.
    Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotechnology and the plasma fractionation industry--the impact of advances in the production of coagulation factor VIII.
    Farrugia A
    Australas Biotechnol; 1993; 3(1):16-20. PubMed ID: 7763537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recovery of factor VIII from fresh-frozen indated and outdated human plasma.
    Whitman DE; Switzer ME; McKee PA
    Thromb Haemost; 1976 Aug; 36(1):71-7. PubMed ID: 1036829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interest of the continuous siphoning method in obtaining cryoprecipitates with higher factor VIII content. Comparison with the conventional and frozen centrifugation methods ].
    González Aza C; Jean Paul E; González Silva M; León Lara A
    Sangre (Barc); 1982; 27(2):223-7. PubMed ID: 6812227
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors influencing factor VIII activity in frozen plasma.
    Swärd-Nilsson AM; Persson PO; Johnson U; Lethagen S
    Vox Sang; 2006 Jan; 90(1):33-9. PubMed ID: 16359353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality parameters of cryoprecipitates from stored blood preservation].
    Schlaack P; Weippert M; Wilms K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):716-9. PubMed ID: 2435639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factor VIII concentrate, highly purified and heated in solution (author's transl)].
    Heimburger N; Schwinn H; Gratz P; Lüben G; Kumpe G; Herchenhan B
    Arzneimittelforschung; 1981; 31(4):619-22. PubMed ID: 6788045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
    Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
    Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on cryoprecipitates. 1. Distribution of antihemophilic globulin A (factor VIII) and of thrombocytes in cryoprecipitation].
    Uteg KH; Sander W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(4):322-31. PubMed ID: 4116124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.